ADMA ADMA Bio: Earnings per share for the last twelve months
The annual revenue per unit for ADMA Biologics, as calculated by GURU.Markets quotes, reaches 0.78, which characterizes this valuation parameter. The growth of ADMA Biologics relies on strict FDA control and unique plasma purification patents. However, the business faces pressure from synthetic analogs and market oligopoly, while simultaneously reducing dependence on external laboratories through the localization of supply chains.
Analytical breakdowns and data insights for company ADMA Biologics Inc (ADMA)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital ADMA Biologics|ADMA - Long-Term Liabilities to Capital|Short-Term Debt to Capital ADMA Bio|ADMA - Company Aggregate Debts|Debts to Book Capitalization ADMA Biologics, Inc.|ADMA - Company Long-Term Indebtedness|Company Short-Term Debt ADMA Biologics|Quick Ratio admabiologics.com
- earnings and valuation multiples indicators:
ADMA - Net Profit|Future Profit ADMA Biologics|ADMA - Company Value to Net Income|Forward P/E Multiple ADMA Biologics, Inc.|ADMA - Price/Earnings to Growth Ratio|EV/EBITDA Multiple ADMA Biologics, Inc.|ADMA - Operating income before deduction of amortization|Earnings per share for the last twelve months ADMA Biologics|ADMA - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months admabiologics.com|ADMA - Earnings per share growth in current year|Net earnings per share growth forecast for next year ADMA Biologics
Analysis of all company metrics:ADMA Biologics (ADMA)
ADMA Biologics' proprietary plasma collection centers and patent protection generate high margins that translate directly into earnings per share growth. By analyzing the TTM net income per share distribution on the GURU.Markets platform, an investor can see the total annual income adjusted for share issuance volume, allowing for an objective assessment of the real cost of capital and the risks of buying at local peaks.
Direct competitors
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Protagonist Therapeutics, Inc.|Net earnings per share for the last 12 months IMVT|Net earnings per share (EPS TTM) Kiniksa Corp|Earnings per share for the last twelve months Grifols, S.A. (GRFS)|adaptivebiotech.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Net earnings per one share for the last twelve months|BioCryst Pharmaceuticals Inc - Net earnings per share (EPS TTM)|VERA - Net earnings per share (EPS TTM)|DNTH: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PHVS|Earnings per share for the last twelve months AbCellera Biologics Inc.|Net earnings per share for the last 12 months Tourmaline Bio Inc (TRML)|Net earnings per share (EPS TTM) PGEN|Net earnings per share (EPS TTM) Pharming Corp (PHAR)|Nektar Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year UPB|Zenas Biopharma - Net earnings per share (EPS TTM)|IMNM: Earnings per share for the last twelve months|GOSS: Net earnings per share (EPS TTM)|KALV - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Septerna Inc|Net earnings per one share for the last twelve months pieris.com PVLA|Earnings per share for the last twelve months Savara (SVRA)|Earnings per share for the last twelve months RIGL (Rigel Pharma)|Earnings per share for the last twelve months AnaptysBio Corp ANAB|Astria Corp (ATXS) - Net earnings per one share for the last twelve months|enGene Holdings Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year RAPT Therapeutics Inc. (RAPT)|JBIO: Net earnings per share (EPS TTM)|ACRS - Net earnings per share for the last four quarters|KYTX (Kyverna) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Tiziana Life Sciences, Ltd. (TLSA)|Earnings per share for the last twelve months Cabaletta Bio, Inc. (CABA)|Net earnings per share for the last four quarters ventyxbio.com|Net earnings per share (EPS TTM) THTX (Theratechnologies)|Net earnings per share (EPS TTM) Avalo Therapeutics, Inc. AVTX|Eledon - Net earnings per share (EPS TTM)|AGEN (Agenus, Inc) - Earnings per share for the last 12 months|Climb Bio Inc (CLYM) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Zura Bio Ltd|ATYR (aTyr Pharma) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Adagene Corp|Earnings per share for the last twelve months ImageneBio Inc (IMA)|STTK: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) EQ (Equillium)|Earnings per share for the trailing year CNTB|Immunic Inc - Net earnings per share (EPS TTM)|ATRA - Net earnings per share (EPS TTM)|inflarx.de (IFRX) - Earnings per share for the last twelve months|X4 Pharmaceuticals, Inc - Earnings per share for the trailing year|Earnings per share for the last twelve months Adicet Bio Inc.|Net earnings per share for the last 12 months Celularity Corp (CELU)|Net earnings per share (EPS TTM) INMB|Net earnings per share (EPS TTM) Barinthus Biotherapeutics PLC (BRNS)|Kezar Life Sciences, Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year SABS|Akari Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Enlivex Therapeutics ENLV|q32bio.com (QTTB) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months GeoVax Labs|Earnings per share for the last twelve months Edesa|Net earnings per share for the last 12 months iBio Corporation (IBIO)|Net earnings per share for the last 12 months CARM (Carisma Therapeutics)|Net earnings per share (EPS TTM) xtlbio.com (XTLB)|Earnings per share for the last twelve months Bolt Biotherapeutics, Inc. BOLT|HCWB: Earnings per share for the last 12 months|Aptevo - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AIM ImmunoTech, Inc.|ADTX: Net earnings per share (EPS TTM)|gribio.com (GRI) - Net earnings per share (EPS TTM)|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months HIND (Vyome Holdings Inc.)|Earnings per share for the last twelve months Revelation Bio (REVB)|Net earnings per share for the last 12 months Indaptus Corp INDP|Net earnings per share (EPS TTM) SCNI (Scinai Immunotherapeutics)|Net earnings per share (EPS TTM) CalciMedica Inc CALI|AFMD: Net earnings per share for the last 12 months|Earnings per share for the trailing year ALLK (Allakos Inc.)|HOOK: Net earnings per share (EPS TTM)|IGMS (IGM Biosciences) - Earnings per share for the last twelve months|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|oceanbiomedical.com (OCEA) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months TC BioPharm (TCBP)|THRD - Net earnings per one share for the last twelve months
